Literature DB >> 33436614

Mechanisms of muscle atrophy and hypertrophy: implications in health and disease.

Roberta Sartori1,2, Vanina Romanello3,4, Marco Sandri5,6,7,8.   

Abstract

Skeletal muscle is the protein reservoir of our body and an important regulator of glucose and lipid homeostasis. Consequently, the growth or the loss of muscle mass can influence general metabolism, locomotion, eating and respiration. Therefore, it is not surprising that excessive muscle loss is a bad prognostic index of a variety of diseases ranging from cancer, organ failure, infections and unhealthy ageing. Muscle function is influenced by different quality systems that regulate the function of contractile proteins and organelles. These systems are controlled by transcriptional dependent programs that adapt muscle cells to environmental and nutritional clues. Mechanical, oxidative, nutritional and energy stresses, as well as growth factors or cytokines modulate signaling pathways that, ultimately, converge on protein and organelle turnover. Novel insights that control and orchestrate such complex network are continuously emerging and will be summarized in this review. Understanding the mechanisms that control muscle mass will provide therapeutic targets for the treatment of muscle loss in inherited and non-hereditary diseases and for the improvement of the quality of life during ageing.

Entities:  

Year:  2021        PMID: 33436614     DOI: 10.1038/s41467-020-20123-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  92 in total

Review 1.  Muscle as a "mediator" of systemic metabolism.

Authors:  Kedryn K Baskin; Benjamin R Winders; Eric N Olson
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

2.  Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation.

Authors:  Bert Blaauw; Marta Canato; Lisa Agatea; Luana Toniolo; Cristina Mammucari; Eva Masiero; Reimar Abraham; Marco Sandri; Stefano Schiaffino; Carlo Reggiani
Journal:  FASEB J       Date:  2009-08-06       Impact factor: 5.191

3.  FoxO-dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension.

Authors:  Lorenza Brocca; Luana Toniolo; Carlo Reggiani; Roberto Bottinelli; Marco Sandri; Maria Antonietta Pellegrino
Journal:  J Physiol       Date:  2016-12-12       Impact factor: 5.182

4.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle.

Authors:  A Musarò; K McCullagh; A Paul; L Houghton; G Dobrowolny; M Molinaro; E R Barton; H L Sweeney; N Rosenthal
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

5.  A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification.

Authors:  Giorgia Pallafacchina; Elisa Calabria; Antonio L Serrano; John M Kalhovde; Stefano Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

6.  Field, clinical and pathological observations of a runting and stunting syndrome in broilers.

Authors:  R L Reece; P T Hooper; S H Tate; V D Beddome; W M Forsyth; P C Scott; D A Barr
Journal:  Vet Rec       Date:  1984-11-10       Impact factor: 2.695

7.  Physical exercise stimulates autophagy in normal skeletal muscles but is detrimental for collagen VI-deficient muscles.

Authors:  Paolo Grumati; Luisa Coletto; Alvise Schiavinato; Silvia Castagnaro; Enrico Bertaggia; Marco Sandri; Paolo Bonaldo
Journal:  Autophagy       Date:  2011-12       Impact factor: 16.016

Review 8.  mTOR at the nexus of nutrition, growth, ageing and disease.

Authors:  Grace Y Liu; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2020-01-14       Impact factor: 94.444

9.  PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription.

Authors:  Marco Sandri; Jiandie Lin; Christoph Handschin; Wenli Yang; Zoltan P Arany; Stewart H Lecker; Alfred L Goldberg; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

10.  Ras is involved in nerve-activity-dependent regulation of muscle genes.

Authors:  M Murgia; A L Serrano; E Calabria; G Pallafacchina; T Lomo; S Schiaffino
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

View more
  62 in total

Review 1.  Understanding of sarcopenia: from definition to therapeutic strategies.

Authors:  Jee Won Kim; Ryuni Kim; Hyerim Choi; Sang-Jin Lee; Gyu-Un Bae
Journal:  Arch Pharm Res       Date:  2021-09-18       Impact factor: 4.946

Review 2.  Impaired regenerative capacity contributes to skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Ariel Jaitovich
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-22       Impact factor: 5.282

Review 3.  Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies.

Authors:  Mohammad Hassan Baig; Khurshid Ahmad; Jun Sung Moon; So-Young Park; Jeong Ho Lim; Hee Jin Chun; Afsha Fatima Qadri; Ye Chan Hwang; Arif Tasleem Jan; Syed Sayeed Ahmad; Shahid Ali; Sibhghatulla Shaikh; Eun Ju Lee; Inho Choi
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

4.  Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid-induced skeletal muscle atrophy.

Authors:  Lin Yin; Na Li; Weihua Jia; Nuoqi Wang; Meidai Liang; Jiamin Shang; Guifen Qiang; Guanhua Du; Xiuying Yang
Journal:  Clin Transl Med       Date:  2022-05

5.  SS-31 does not prevent or reduce muscle atrophy 7 days after a 65 kdyne contusion spinal cord injury in young male mice.

Authors:  Zachary A Graham; Jennifer J DeBerry; Christopher P Cardozo; Marcas M Bamman
Journal:  Physiol Rep       Date:  2022-05

6.  A Tead1-Apelin axis directs paracrine communication from myogenic to endothelial cells in skeletal muscle.

Authors:  Umji Lee; Pascal Stuelsatz; Sonia Karaz; David W McKellar; Julie Russeil; Maria Deak; Iwijn De Vlaminck; Christoph Lepper; Bart Deplancke; Benjamin D Cosgrove; Jerome N Feige
Journal:  iScience       Date:  2022-06-14

7.  G6PD Deficiency Is Crucial for Insulin Signaling Activation in Skeletal Muscle.

Authors:  Aiwen Jiang; Hongyun Guo; Xiaoyu Jiang; Jingli Tao; Wangjun Wu; Honglin Liu
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

Review 8.  Biology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy.

Authors:  Scott M Ebert; Blake B Rasmussen; Andrew R Judge; Sarah M Judge; Lars Larsson; Ronald C Wek; Tracy G Anthony; George R Marcotte; Matthew J Miller; Mark A Yorek; Adrian Vella; Elena Volpi; Jennifer I Stern; Matthew D Strub; Zachary Ryan; John J Talley; Christopher M Adams
Journal:  J Nutr       Date:  2022-04-01       Impact factor: 4.798

Review 9.  Nutraceuticals in the Prevention and Treatment of the Muscle Atrophy.

Authors:  Yanan Wang; Qing Liu; Helong Quan; Seong-Gook Kang; Kunlun Huang; Tao Tong
Journal:  Nutrients       Date:  2021-06-02       Impact factor: 5.717

10.  MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms.

Authors:  Arshiya Parveen; Kyle R Bohnert; Meiricris Tomaz da Silva; Yefei Wen; Raksha Bhat; Anirban Roy; Ashok Kumar
Journal:  FASEB J       Date:  2021-08       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.